CSIMarket
 


Aerie Pharmaceuticals Inc   (AERI)
Other Ticker:  
 


Aerie Pharmaceuticals Inc 's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



AERI Net Cash Flow Margin (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Revenue Change 23.25 % 22.53 % 29.89 % 364.55 % 45.97 %
Seq. Revenue Change 8.46 % 11.65 % -73.98 % 291.18 % 7.83 %
Revenue In Millions $36.13 $33.31 $29.84 $114.67 $29.31
Net Cash Flow Margin 40.55 % -51.03 % 64.53 % -21.51 % -61.78 %
Net Cash Flow Margin Total Ranking # 587 # # 443 # #
Net Cash Flow In Millions $14.65 $-17.00 $19.25 $-24.66 $-18.11
Y / Y Net Cash Flow Change - - - - -
Seq. Net Cash Flow Change - - - - -


Commenting Third Quarter 2022 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in III. Quarter to 40.55 %, a new company low.

Observing third quarter 2022 results within Biotechnology & Pharmaceuticals industry 32 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 587.

AERI's Net Cash Flow Margin third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 33
Healthcare Sector # 166
Overall # 586

Net Cash Flow Margin Statistics
High Average Low
872.76 % 277.5 % 40.55 %
(Jun 30 2018)   (Sep 30 2022)




Other Net Cash Flow Margin Profitability Ratios
AERI's Cumulative Net Cash Flow Margin
Biotechnology & Pharmaceuticals Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
AERI's Net Cash Flow Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for AERI's Competitors
Net Cash Flow Margin Profit Margin for Aerie Pharmaceuticals Inc 's Suppliers
Net Cash Flow Margin Profit Margin for AERI's Customers

You may also want to know
AERI's Annual Growth Rates AERI's Profitability Ratios AERI's Asset Turnover Ratio AERI's Dividend Growth
AERI's Roe AERI's Valuation Ratios AERI's Financial Strength Ratios AERI's Net Cash Flow Growth
AERI's Roa AERI's Inventory Turnover Ratio AERI's Growth Rates AERI's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Net Cash Flow MarginSep 30 2022 MRQ Net Cash FlowSep 30 2022 MRQ Revenue
Poseida Therapeutics Inc   87.57 %$ 101.844 $ 116.306 
Alector Inc   80.57 %$ 11.966 $ 14.852 
Sutro Biopharma Inc   70.24 %$ 17.664 $ 25.147 
Amgen Inc   64.63 %$ 4,299.000 $ 6,652.000 
Voyager Therapeutics Inc   45.10 %$ 18.531 $ 41.086 
Biogen Inc   43.11 %$ 1,081.300 $ 2,508.500 
Aerie Pharmaceuticals Inc   40.55 %$ 14.651 $ 36.129 
Mymetics Corporation  39.23 %$ 0.057 $ 0.146 
Ainos Inc   37.87 %$ 0.666 $ 1.758 
Halozyme Therapeutics Inc   26.91 %$ 56.227 $ 208.976 
Coherus Biosciences inc   24.92 %$ 11.321 $ 45.424 
Champions Oncology Inc   19.38 %$ 2.768 $ 14.281 
Neurocrine Biosciences Inc   12.61 %$ 48.900 $ 387.900 
Exelixis Inc   9.49 %$ 39.082 $ 411.738 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com